EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut-on-a-Chip Research for Drug Development: Implications of Chip Design on Preclinical Oral Bioavailability or Intestinal Disease Studies

Joanne M Donkers iD, Jamie I van der Vaart iD, Evita van de Steeg

Biomimetics · 28.05.2023 · 8 (2) · 226

DOI: 10.3390/biomimetics8020226 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomimetics, online erschienen am 28.05.2023. Verfasst von Joanne M Donkers und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolic Health Research, TNO, Sylviusweg 71, 2333 BE Leiden, The Netherlands. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut plays a key role in drug absorption and metabolism of orally ingested drugs. Additionally, the characterization of intestinal disease processes is increasingly gaining more attention, as gut health is an important contributor to our overall health. The most recent innovation to study intestinal processes in vitro is the development of gut-on-a-chip (GOC) systems. Compared to conventional in vitro models, they offer more translational value, and many different GOC models have been presented over the past years. Herein, we reflect on the almost unlimited choices in designing and selecting a GOC for preclinical drug (or food) development research. Four components that largely influence the GOC design are highlighted, namely (1) the biological research questions, (2) chip fabrication and materials, (3) tissue engineering, and (4) the environmental and biochemical cues to add or measure in the GOC. Examples of GOC studies in the two major areas of preclinical intestinal research are presented: (1) intestinal absorption and metabolism to study the oral bioavailability of compounds, and (2) treatment-orientated research for intestinal diseases. The last section of this review presents an outlook on the limitations to overcome in order to accelerate preclinical GOC research.

Schlagwörter

Stichwörter der Autor:innen

ADMEIBDdrug developmentex vivogut-on-a-chipin vitrointestinemicrobiomeoral bioavailabilityorgan-on-a-chip

Autor:innen und Institutionen

  • Department of Metabolic Health Research, TNO, Sylviusweg 71, 2333 BE Leiden, The Netherlands.
  • Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
  • Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

ORCID-Profile: Joanne M Donkers, Jamie I van der Vaart

Zitieren

APA

Donkers, J. M., van der Vaart, J. I., & van de Steeg, E. (2023). Gut-on-a-Chip Research for Drug Development: Implications of Chip Design on Preclinical Oral Bioavailability or Intestinal Disease Studies. Biomimetics, 8(2), 226. https://doi.org/10.3390/biomimetics8020226

Vancouver

Donkers JM, van der Vaart JI, van de Steeg E. Gut-on-a-Chip Research for Drug Development: Implications of Chip Design on Preclinical Oral Bioavailability or Intestinal Disease Studies. Biomimetics. 2023;8(2):226. doi:10.3390/biomimetics8020226

BibTeX
@article{Donkers2023,
  author = {Donkers, Joanne M and van der Vaart, Jamie I and van de Steeg, Evita},
  title = {Gut-on-a-Chip Research for Drug Development: Implications of Chip Design on Preclinical Oral Bioavailability or Intestinal Disease Studies},
  journal = {Biomimetics},
  year = {2023},
  volume = {8},
  number = {2},
  pages = {226},
  doi = {10.3390/biomimetics8020226}
}
Kostenlos starten →